Ask AI
ProCE Banner Activity

Treatment Patterns for del(17P)/Mutated TP53 or Relapsed/Refractory (R/R) CLL Among Experts and Lower-Volume Treaters

PDF

This poster, presented at the 2025 ASCO Quality Care Symposium, features data from an online treatment decision support tool demonstrating variance in how experts and community healthcare professionals manage patients with previously untreated CLL with del(17p)/mutated TP53 or relapsed/refractory CLL, indicating an area of ongoing educational need.

Released: October 10, 2025

Share